Global /China /Healthcare /Biotechnology /688253

Innovita Biological Technology Co., Ltd.

688253

• SSE: 688253 • Delayed

48.26CNY 3.7%

7.13 USD

As of 15 June 2026, Innovita Biological Technology Co., Ltd. has a market cap of $1.04B USD, ranking #10512 globally and #2941 in China. It ranks #943 in the Healthcare sector, and #177 in the Biotechnology industry.

Global Rank

10512

Country Rank

2941

Sector Rank

943

Industry Rank

177

Key Stats

Market Cap

$1.04BUSD

7.02B CNY

Enterprise Value

$764.88MUSD

5.18B CNY

Revenue (TTM)

$62.28MUSD

422.03M CNY

EBITDA (TTM)

$26.48MUSD

179.22M CNY

Net Income (TTM)

$21.55MUSD

146.04M CNY

EBITDA Margin

42%

Profit Margin

35%

PE Ratio

48.6

Forward PE

41.3

PS Ratio

16.6

PB Ratio

3.5

EV/EBITDA

28.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Xiujie Zhang open_in_new

Employees

558

Founded

2006

Website

innovita.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.7%	0%	32%	31%	54%	60%	57%	78%	73%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688253 北京英诺特生物技术股份有限公司 Class A ISIN: CNE100005Q14 Shares Out.: Shares Outstanding: 69.337M¹ Shares Float: 69.322M² TV: TradingView: SSE: 688253 SA: Stock Analysis: SHA: 688253 YF: Yahoo Finance: 688253.SS GF: Google Finance: SHA: 688253 BA: Barron's: 688253 MS: Morningstar: XSHG: 688253	48.26 CNY	TV: TradingView: SSE: 688253 SA: Stock Analysis: SHA: 688253 YF: Yahoo Finance: 688253.SS GF: Google Finance: SHA: 688253 BA: Barron's: 688253 MS: Morningstar: XSHG: 688253

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Innovita Biological Technology Co., Ltd.

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 2K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 1K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.0B 54.23B CNY 673%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.33B 49.69B CNY 608%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 584%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 548%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 18K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 15K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 5K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 4K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 4K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 4K%	37.2	Switzerland

chevron_leftBack